# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 2c39:B (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
2 | 2c39:D (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
3 | 2c39:F (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
4 | 2c39:H (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
5 | 2c39:J (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
6 | 2c39:L (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
7 | 2c39:N (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
8 | 2c39:P (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
9 | 2c39:R (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
10 | 2c39:T (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
11 | 2c39:V (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 | |
12 | 2c39:X (3.3) | BS01 | ADP | 3.1.13.- | GO:0000175 ... | Q9UXC2 | 16285928 |